Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.
Industry sector: Medical
Sector classification: Pharmaceutical preparations
Deep Learning based analysis and prediction model for Zoetis Inc. (ZTS) stock is a 2nd Generation Non-linear Autoregressive (NAR) model based on the LSTM/GRU Recurrent Neural Network architecture.
Model is in the production pipeline since Oct. 22, 2015.
Market data for ZTS model training are being downloaded from the Quandl premium datasets on a daily basis.
Model is being retrained on a regular basis.
|% Held by Insiders||0.35%|
|% Held by Institutions||92.60%|
|EPS (last reported FY)||$2.40|
|EPS (last reported Q)||$0.75|
|EPS, estimated (last reported Q)||$0.70|
|Total revenues||$5 B|
|Net income||$1 B|